Contagious agalactia
OIE Reference Laboratory Reports
Activities in 2011
Name of disease (or topic) for which you are a designated OIE Reference Laboratory: / Contagious agalactiaAddress of laboratory: / Animal Health and Veterinary Laboratories Agency
Woodham Lane,
Addlestone,
Surrey, KT15 3NB,
UNITED KINGDOM
Tel.: / Tel.: (+44-1932) 35.73.79
Fax: / Fax:(+44-1932) 35.74.23
e-mail address: /
website: / http://www.defra.gov.uk/vla/diseases/dis_mycoplasma.htm
Name (including Title and Position) of Head of Laboratory (Responsible Official): / Miss Catherine Brown
Name(including Title and Position) of OIE Reference Expert: / Professor Robin A.J. Nicholas
Name (including Title and Position) of writer of this report
(if different from above):
Part I: Summary of general activities related to the disease
The Mycoplasma Group at the AHVLA performs diagnosis and research into all aspects of animal mycoplasmology including as a contagious agalactia-free country monitoring small ruminant herds for diseases suggestive of CA. We also perform fundamental studies into the behaviour of M agalactiae and related CA mycoplasmas including the effects of biofilm formation on survival and pathogenicity. We have created a universal molecular typing scheme to enable the classification of isolates and help disease tracing. We routinely perform antibiotic sensitivity tests on mycoplasma isolates
1. Test(s) in use/or available for the specified disease/topic at your laboratory
Total
Test / For / Animal /Surveillance
/Diagnosis
ELISA / Antibody / Sheep / 2 / 0CFT / Antibody / Goat / 0 / 0
Immunoblotting
/ Antibody / Sheep and goat / 0 / 0Mycoplasma isolation
/ Mycoplasma organisms / Sheep and goat / 0 / 0PCR/DGGE*
/ Mycoplasma DNA / Sheep and goat / 49* Denaturing gradient gel electrophoresis (McAuliffe et al., 2005)
2. Production and distribution of diagnostic reagents
Antigen for the ELISA for antibodies to M agalactiae was provided to our laboratory testing division at AHVLA
Part II: Activities specifically related to the mandate
of OIE Reference Laboratories
3. International harmonisation and standardisation of methods for diagnostic testing or the production and testing of vaccines
a) Establishment and maintenance of a network with other OIE Reference Laboratories designated for the same pathogen or disease and organisation of regular inter-laboratory proficiency testing to ensure comparability of results
None
b) Organisation of inter-laboratory proficiency testing with laboratories other than OIE Reference Laboratories for the same pathogens and diseases to ensure equivalence of results
None
4. Preparation and supply of international reference standards for diagnostic tests or vaccines
None
5. Research and development of new procedures for diagnosis and control
In an effort to develop improved diagnostic tests for contagious agalactia, representative strains of the causative mycoplasmas: M agalactiae, M mycoides subsp capri and M capricolum subsp. capricolum were analysed by 2-D electrophoresis. Unique proteins were identified by MudPIT analysis and immunogenic proteins were matched by mass spectrometry. A number of proteins were identified from each mycoplasma species that could be used as antigens in a diagnostic test. Real time PCRs have also been assessed for their ability to detect causative mycoplasmas in clinical material. They were found to be 100 time more sensitive than conventional PCRs and easier to standardise and automate. Further validation is required before they can be used in routine diagnosis
6. Collection, analysis and dissemination of epizootiological data relevant to international disease control
Sheep flocks from three prefectures of Japan, Hokkaido, Iwate and Aumori, were screened for antibodies to Mycoplasma agalactiae by indirect ELISA. None of the 246 sera were serologically positive suggesting that this region is free of contagious agalactia
7. Maintenance of a system of quality assurance, biosafety and biosecurity relevant to the pathogen and the disease concerned
ISO 17025 and ISO9001-2008 audited by Lloyds Registry Quality Assessors on behalf of United Kingdom Accreditation System. We follow Advisory Committee on Dangerous Pathogens for handling live mycoplasma in containment level 2 facility using class II microbiological safety cabinets and follow stipulations set by the Specified Animal Pathogens Order..
8. Provision of consultant expertise to OIE or to OIE Member Countries
RN chaired a group of experts to analyse information gaps in our knowledge of contagious agalactia under the EU DISCONTOOLS initiative. A report was submitted
9. Provision of scientific and technical training to personnel from other OIE Member Countries
Staff from Italy (1) and Czech Republic (1) were trained in diagnostic and research methods concerning ruminant mycoplasmas including those causing contagious aglactia
We began discussions with the CVDRL in Kabul, Afghanistan under the twinning initiative. This process will begin in early 2012 and will cover mycoplasma diseases of small ruminants including those causing contagious agalactia
10. Provision of diagnostic testing facilities to other OIE Member Countries
None
11. Organisation of international scientific meetings on behalf of OIE or other international bodies
We organised an international meeting on mycoplasmas at AHVLA in June 2011 entitled “Whats new in Mycoplasmology” which attreacted nearly 100 delegates from Europe, Middle East, Africa and the USA. This included talks on contagious agalactia, diagnostics, vaccines and molecular epidemiology
12. Participation in international scientific collaborative studies
None
13. Publication and dissemination of information relevant to the work of OIE (including list of scientific publications, internet publishing activities, presentations at international conferences)
¡ Presentations at international conferences and meetings
Nicholas, R.A.J. Molecular typing –a guide. Immunologia e benessere animale: strumente e indicatori della sanita pubblica veterinaria, IZS Sicilia Feb 2011
¡ Scientific publications in peer-reviewed journals
La Manna, M.P. Agnone, A. Villari, S. Puleio, R. Vitale, M. Nicholas, R. Sireci, G., Dieli F. and Loria G.R. (2011)Expansion of intracellular IFN-γ positive lymphocytes during Mycoplasma agalactiae infection in sheep. Research in Veterinary Science doi: 10.1016/j.rvsc 2011.01.029
Giangaspero, M., Nicholas, RAJ., Hlusek, M., Orusa, R. & Ayling, RD (2011)Seroepidemiological survey of sheep flocks from Northern Japan for Mycoplasma ovipneumniae and M. agalactiae. Tropical Animal Health and Production DOI 10.1007/s11250-011-9952-8
______
Annual reports of OIE Reference Centres, 2011 3